Turkish Validation of the ALOC Screening Scale in Older Adults
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age65+
SponsorToros University
About this trial
As the elderly population increases, health problems related to aging are also increasing. Loss of appetite negatively affects public health by causing malnutrition and related health problems in elderly individuals. Loss of appetite is a common problem in older adults, both in individuals with and without cognitive impairment. This can lead to serious health problems such as malnutrition, weight loss, muscle loss, weakening of the immune system and decreased quality of life. Cognitive disorders such as Alzheimer's and dementia can trigger loss of appetite, or loss of appetite can be a symptom of these disorders. Factors such as metabolic changes during the aging process, decreased sense of taste and smell, loneliness and depression contribute to loss of appetite. However, there is no valid and reliable scale in Turkey for the early diagnosis and assessment of loss of appetite. A scale being valid and reliable means that it can measure the concept it is intended to measure accurately and consistently. The aim of this study was to determine the validity and reliability of the Turkish version of the Loss of Appetite Scale in older adults with and without cognitive impairment .
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Elderly over 65 years, with or without cognitive impairment
Disqualifiers
None
Trial population
The data collection process of the research will be carried out in four different nursing homes in Mersin province, namely Mersin Aid and Kindness Foundation Retirement Home, Mersin Sevgi Bağı Retirement Home, Private Mersin Bahar Retirement Home and Private Alya Elderly Care Center and Retirement Home. The interviews will be conducted in an atmosphere suitable for the participants to express themselves in a comfortable and safe environment. In addition, within the framework of ethical rules, the participants will be included in the research on a voluntary basis and the confidentiality of their information will be protected. The collected data will be analyzed in line with the purpose of the research and the results will be evaluated.
Trial design
Design model
Ecologic or community
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
300 Participants
are grouped into 2 trial groupsGroup A: Elderly with or without cognitive impairment
Group B: The data collection process of the research will be carried out in four different nursing homes.
Trial outcomes
Primary outcomes
1
Validity and Reliability of the Turkish Version of the Appetite Loss in Older Adults With and Without Cognitive Impairment (ALOC) Screening Scale
Loss of appetite is common in older adults and increases the risk of malnutrition, functional decline, and adverse health outcomes. Older adults with cognitive impairment are particularly vulnerable. The Appetite Loss in Older Adults With and Without Cognitive Impairment (ALOC) Screening Scale, developed by Rudzinska et al. (2025), consists of 7 dichotomous items scored 0-7, with cut-offs indicating appetite loss (≥3), risk (=2), or low risk (≤1). This study aims to adapt the ALOC into Turkish and evaluate its psychometric properties in adults ≥65 years with and without cognitive impairment. Internal consistency, test-retest reliability, factor structure, convergent and known-groups validity, and diagnostic accuracy will be tested. Predictive validity will be assessed through nutritional and clinical outcomes over 3 months. The validated Turkish ALOC is expected to provide a practical screening tool to support early detection and management of appetite loss in geriatric care.
Time frame
From enrollment to the end of treatment at 12 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: